Practice Point®: Hematology | Podcast in RSS.com

Practice Point®: Hematology

Practice Point®: Hematology

di Practice Point Communications

Episode 46 - What's New Doc? End-of-the-Year Updates on CAR T-cell Therapy in Multiple Myeloma Podcast

CAR T-cell therapies have transformed the management of several previously incurable, treatment-refractory hematologic malignancies, including Multiple Myeloma (MM). With two CAR T-cell products now approved, and additional under investigation, the therapeutic landscape continues to evolve rapidly. In this educational podcast, Dr. Joseph Mikhael highlights key advances in CAR T-cell therapy for MM. He reviews the most impactful data published or presented in 2025 and offers expert insight into how these emerging findings may shape current and future treatment strategies. Launch/Release Date: December 17, 2025 Activity Expiration Date: November 30, 2026 FACULTY Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO Professor, Clinical Genomics and Therapeutics Translational Genomics Research Institute (TGen), City of Hope Cancer Center Chief Medical Officer International Myeloma Foundation This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Episode 45 - Clinical Clips® Crucial Advances in Hemophilia

A number of clinical trials are underway to reduce and prevent bleeding episodes among patients with hemophilia and to improve their overall quality of life by improving joint health and addressing patient needs/concerns. These include both replacement and novel non-replacement therapies. This activity is designed to update healthcare professionals with the latest cutting-edge evidence in hemophilia treatment that was presented during the annual hematology meeting in Orlando, FL. The Clinical Clips format will equip clinicians with the knowledge and confidence to integrate new evidence into personalized approaches, optimize patient outcomes, and improve the overall quality of care in hemophilia A and B. Launch/Release Date: December 12, 2025 Activity Expiration Date: November 30, 2026 FACULTY Angela Weyand, MD Associate Professor, Pediatrics University of Michigan Medical School Pediatric Medical Director University of Michigan HTC Co-Director, Hematology and Pediatric and Adolescent Gynecology Program Ann Arbor, Michigan This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Episode 44 - Hematologic Cancer Updates | Key Advances in Leukemia, MDS and MF Podcast

Breakthroughs in hematologic cancers continue to emerge. Staying aligned with the newest insights from leading medical conferences is essential for healthcare providers committed to delivering cutting-edge care. Through impactful presentations, posters and abstracts, Dr. Raajit Rampal provides expert commentary on the latest advances in Leukemia, Myelodysplastic Syndromes (MDS) and Myelofibrosis (MF) presented at the annual hematology meeting in Orlando, FL. Launch/Release Date: December 10, 2025 Activity Expiration Date: November 30, 2026 FACULTY Raajit Rampal, MD, PhD Director, Myeloproliferative Neoplasms Program Director, Center for Hematologic Malignancies Memorial Sloan Kettering Cancer Center This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Episode 43 - Integrating Emerging Therapies into Clinical Practice for Pediatric ITP: Exploring Evidence, Guidelines and Best Practices

In this podcast, Dr. Cindy Neunert, provides expert insights into emerging data on ITP pathophysiology, diagnosis, and treatment, equipping healthcare providers with the knowledge to translate new research into clinical practice and improve pediatric patient care. Launch Date: July 7, 2025 Release Date: July 7, 2025 Expiration Date: June 30, 2026 FACULTY Cindy Neunert, MD Division of Pediatric Hematology Oncology, and Stem Cell Transplantation Columbia University Irving Medical Center New York, New York This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Episode 42 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 4: Patient Perspective in Hemophilia Care

There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways. Launch Date: February 4, 2025 Release Date: February 4, 2025 Expiration Date: January 31, 2026 FACULTY Jonathan C. Roberts, MD Associate Medical Director Associate Research Director Bleeding and Clotting Disorders Institute Associate Professor of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Mindy Simpson, MD Medical Director Rush Hemophilia and Thrombophilia Center Assistant Professor of Pediatrics in Pediatric Hematology/Oncology Rush University Medical Center This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.

Episode 41 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 3: Relevance and Impact of Novel Agents in Hemophilia Care Paradigms

There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways. Launch Date: February 4, 2025 Release Date: February 4, 2025 Expiration Date: January 31, 2026 FACULTY Jonathan C. Roberts, MD Associate Medical Director Associate Research Director Bleeding and Clotting Disorders Institute Associate Professor of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Mindy Simpson, MD Medical Director Rush Hemophilia and Thrombophilia Center Assistant Professor of Pediatrics in Pediatric Hematology/Oncology Rush University Medical Center This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.

Episode 40 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 2: Clinical Evidence on Novel Therapy Options in Hemophilia

There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways. Launch Date: February 4, 2025 Release Date: February 4, 2025 Expiration Date: January 31, 2026 FACULTY Jonathan C. Roberts, MD Associate Medical Director Associate Research Director Bleeding and Clotting Disorders Institute Associate Professor of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Mindy Simpson, MD Medical Director Rush Hemophilia and Thrombophilia Center Assistant Professor of Pediatrics in Pediatric Hematology/Oncology Rush University Medical Center This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.

Episode 39 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 1: Rationale and Potential of Gene Therapy and Rebalancing Agents in Hemophilia

There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways. Launch Date: February 4, 2025 Release Date: February 4, 2025 Expiration Date: January 31, 2026 FACULTY Jonathan C. Roberts, MD Associate Medical Director Associate Research Director Bleeding and Clotting Disorders Institute Associate Professor of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Mindy Simpson, MD Medical Director Rush Hemophilia and Thrombophilia Center Assistant Professor of Pediatrics in Pediatric Hematology/Oncology Rush University Medical Center This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.

Episode 38 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 5: Secondary HLH/MAS & Updates from ASH

Conversations in IFN-y explores the latest advancements in understanding and managing secondary hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS), with updates from ASH 2024. Featuring discussions by leading experts, the educational activity covers breakthroughs in diagnostic technologies. Topics covered include AI-based histology models and PET/CT imaging, therapeutic innovations such as emapalumab and reduced-intensity conditioning for HSCT. The implications of these findings for improving outcomes in diverse patient populations, including malignancy- and pregnancy-associated HLH will also be discussed. Launch Date: January 9, 2025 Release Date: January 9, 2025 Expiration Date: December 31, 2025 FACULTY Pui Lee, MD Assistant Professor of Pediatrics Boston Childrens Hospital Ashish Kumar, MD, PhD Professor of Pediatrics Cincinnati Children's Hospital Medical Center Alexei Grom, MD Professor of Pediatrics Research Director Division of Rheumatology Cincinnati Children’s Hospital Medical Center This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

Epsiode 37 - What’s New Doc? End of the Year Updates on CAR T-cell Therapy in Multiple Myeloma

What’s New Doc?: CAR T-cells in Multiple Myeloma, highlights key studies and publications from 2024 on the use of these agents in earlier lines of treatment. Dr. Mikhael details how approved and emerging CAR T cell agents in multiple myeloma will impact the treatment landscape and how to better integrate these agents to enable improved outcomes among patients. Launch Date: December 19, 2024 Release Date: December 19, 2024 Expiration Date: November 30, 2025 FACULTY Joseph Mikhael, MD, MEd, FRCPC, FACP Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center Chief Medical Officer, International Myeloma Foundation Consultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research Institute Adjunct Professor, College of Health Solutions, Arizona State University This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

1 di 5